Navigation Links
Results of TactioRPM Pilot in a Senior Home Unveiled at Stanford Med X Conference
Date:9/26/2015

MONTREAL, Sept. 26th, 2015 /PRNewswire/ -- Results of a TactioRPM pilot project in a senior home will be unveiled today at the Stanford Medicine X Conference. In a presentation titled "Senior Patient Engagement Using iPad Dashboards, Connected Health Devices and Pharmacogenomics", Roger Simard, Pharmacist and Founder of Pharmacy 3.0, will explain how senior patients equipped with connected health devices and sending over data to their pharmacist via the TactioRPM remote patient monitoring platform were empowered to make significant lifestyle changes losing weight and taking charge of their chronic conditions.

Photo - http://photos.prnewswire.com/prnh/20150926/271069

The pilot, a joint effort between Tactio Health Group and Pharmacy 3.0, equipped 40 residents between the ages of 60 and 89 with health monitoring devices as appropriate to their condition such as scales, blood pressure monitors and glucometers, and each received activity trackers that tallied their steps. These devices were connected wirelessly to either an iPad-hosted dashboard app or a digital hub that was deployed both at the pharmacy and at the senior facility. The biometric data was collected and analyzed by the Tactio RPM7000 secured cloud platform who then made it available for both patients and pharmacist to view on their respective dashboards.

Among the numerous apps and devices supported by TactioRPM, Pharmacy 3.0 selected specific devices from A&D Medical, Garmin and Glooko for their ease of use with elders. Also worth mentioning is the use of Amiigo that notoriously allowed to flag a patient who was found to have previously undiagnosed atrial fibrillation.

"When Roger came to Tactio in 2014 asking to help support his project, I was fascinated by his vision and determination to improve senior care with mobile technologies and connected health devices. There is a common belief that seniors can't use these technologies effectively, yet we were amazed to see how fast Roger's group embraced our platform and how enthusiast they were using technology to engage with their pharmacist. These patients deserve a lot of credit." said Michel Nadeau, P.Eng., CEO of Tactio Health Group.

"The project was successful beyond expectations", summarizes Roger Simard. "Participants, many of whom had never used computers or devices before the pilot, became not only more knowledgeable about their condition but also far more aware when their biometric parameters weren't within target range."

Based on the pilot's success, Le Groupe Maurice (senior home) has already expanded the initiative to three additional facilities and plans to implement pharmacist-directed remote monitoring in all of its residences. A Quebec based pharmacy chain, who funded the initial pilot, also plans to deploy TactioRPM in 15 of its pharmacies this fall. In those sites, pharmacists will remotely monitor patients with so-called Syndrome X – hypertension, diabetes and high cholesterol – to see if the approach can improve patients' condition management and/or health status.

For more details on this pharmacist-led pilot program, please see the associated case study available at www.tactiohealth.com/case-studies/pharmacist-led-telemonitoring-pilot.

For more details on the Stanford Medicine X presentation, please see the online reference at http://medicinex.stanford.edu/conf/conference/speaker/633.

About TactioHealth Group

Tactio Health Group, founded in 2009, helps innovative healthcare organizations worldwide tap the power of mobile and connected health to improve clinical research, remote care workflows and patient engagement. The TactioRPM (remote patient monitoring) FDA Class 1 MDDS platform for health professionals and patients combines mobile apps, web tools, HIPAA-compliant, secured cloud services and vendor-agnostic connected health device integrations. TactioRPM is available as a complete end-to-end system and as a platform for innovative healthcare application developers to provide digital coaching for patients with hypertension, diabetes, chronic obstructive pulmonary disease (COPD), congestive heart failure (CHF), atherosclerosis and obesity. Tactio apps have been downloaded by more than 4 million users in 135 countries and 17 languages.

For more information about Tactio, visit www.tactiohealth.com or follow @TactioHealth on Twitter.

About Pharmacy 3.0

Pharmacy 3.0 is a Montreal-based company providing turnkey solutions to the healthcare sector. Pharmacy 3.0 solutions are designed to optimize pharmacotherapy by integrating the combined benefits of a comprehensive connected health mobile patient engagement platform, a clinical software approach enabling pharmaceutical care process in the pharmacy practice and advanced usage of pharmacogenomics.

For more information, visit http://www.pharmacy3dot0.com/.

TactioRPM is a trademark of Tactio Health Group. Other product and company names mentioned herein may be trademarks of their respective companies.


'/>"/>
SOURCE Tactio Health Group
Copyright©2015 PR Newswire.
All rights reserved

Related biology news :

1. AMRI Announces Second Quarter 2015 Results
2. Aware, Inc. Reports Second Quarter 2015 Financial Results
3. Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30
4. Synaptics to Report Third Quarter Results on April 23
5. Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results
6. Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results
7. Alere Inc. Announces Fourth Quarter 2014 Results
8. Clinical results indicate vaccine candidate highly efficacious against bacterial diarrhea
9. Aware, Inc. Reports Third Quarter 2014 Financial Results
10. Results of study of the human mind and consciousness at the time of death available
11. Promising results shown with targeted approaches in subsets of non-small cell lung cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2020)... ... , ... Worldwide Business with kathy ireland® has announced an exclusive ... of Sales and Marketing Jeff Maier to discuss their innovative technology, High-Speed Vibration Therapy. ... 26, 2020 at 5:30 p.m. EST and internationally on Bloomberg Television on Saturday, Jan. ...
(Date:1/22/2020)... (PRWEB) , ... January 21, 2020 , ... Lifecycle Biotechnologies announces the new ... to each users’ unique needs based on their process requirements and accurately weighed to 0.001 ... Buffers , Salts , Sugars , Carbohydrates , ...
(Date:1/7/2020)... ... January 06, 2020 , ... Myant Inc. , the ... Las Vegas) to bring to life its vision of a world where textile-based interfaces ... community, the AI-powered digital sphere, and the physical IoT-enabled environment. The experience at Myant’s ...
Breaking Biology News(10 mins):
(Date:1/10/2020)... PRINCETON, N.J. (PRWEB) , ... January 09, 2020 ... ... the Study of Drug Development establishes benchmarks for the vendor qualification process, ... November/December Impact Report, the process volume and complexity of the vendor qualification process ...
(Date:1/7/2020)... Kingdom (PRWEB) , ... January 07, 2020 , ... ... recombinant antibody products and services, today announced the launch of its VivopureX™ recombinant ... popular antibody clones, many originally obtained from rats or hamsters, which Absolute Antibody ...
(Date:12/31/2019)... ... 31, 2019 , ... Vici Health Sciences announces ... in Maryland. Emphasis will be in expanding capabilities in both oral and parenteral ... be well positioned to meet the growing demand for its pharmaceutical formulation and ...
(Date:12/23/2019)... (PRWEB) , ... December 23, 2019 , ... ... leak detection systems for the Pharmaceutical, Biotechnology and Medical Device Industries, is excited ... at the Parenteral Drug Association (PDA) Container Closure Integrity Testing Basic Training ...
Breaking Biology Technology: